In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi.
Chagas' disease is a neglected tropical disease caused by the kinetoplastid protozoan Trypanosoma cruzi. The only therapies are the nitroheterocyclic chemicals nifurtimox and benznidazole that cause various adverse effects. The need to create safe and effective medications to improve medical ca...
Published in: | PLOS Neglected Tropical Diseases |
---|---|
Main Authors: | , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023
|
Subjects: | |
Online Access: | https://doi.org/10.1371/journal.pntd.0010545 https://doaj.org/article/0abe6a01cc204a61baced8f759d0fab2 |
id |
ftdoajarticles:oai:doaj.org/article:0abe6a01cc204a61baced8f759d0fab2 |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:0abe6a01cc204a61baced8f759d0fab2 2023-05-15T15:11:02+02:00 In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi. Stefano Muscat Gianvito Grasso Leonardo Scapozza Andrea Danani 2023-01-01T00:00:00Z https://doi.org/10.1371/journal.pntd.0010545 https://doaj.org/article/0abe6a01cc204a61baced8f759d0fab2 EN eng Public Library of Science (PLoS) https://doi.org/10.1371/journal.pntd.0010545 https://doaj.org/toc/1935-2727 https://doaj.org/toc/1935-2735 1935-2727 1935-2735 doi:10.1371/journal.pntd.0010545 https://doaj.org/article/0abe6a01cc204a61baced8f759d0fab2 PLoS Neglected Tropical Diseases, Vol 17, Iss 1, p e0010545 (2023) Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 article 2023 ftdoajarticles https://doi.org/10.1371/journal.pntd.0010545 2023-02-19T01:28:16Z Chagas' disease is a neglected tropical disease caused by the kinetoplastid protozoan Trypanosoma cruzi. The only therapies are the nitroheterocyclic chemicals nifurtimox and benznidazole that cause various adverse effects. The need to create safe and effective medications to improve medical care remains critical. The lack of verified T. cruzi therapeutic targets hinders medication research for Chagas' disease. In this respect, cytochrome bc1 has been identified as a promising therapeutic target candidate for antibacterial medicines of medical and agricultural interest. Cytochrome bc1 belongs to the mitochondrial electron transport chain and transfers electrons from ubiquinol to cytochrome c1 by the action of two catalytic sites named Qi and Qo. The two binding sites are highly selective, and specific inhibitors exist for each site. Recent studies identified the Qi site of the cytochrome bc1 as a promising drug target against T. cruzi. However, a lack of knowledge of the drug mechanism of action unfortunately hinders the development of new therapies. In this context, knowing the cause of binding site selectivity and the mechanism of action of inhibitors and substrates is crucial for drug discovery and optimization processes. In this paper, we provide a detailed computational investigation of the Qi site of T. cruzi cytochrome b to shed light on the molecular mechanism of action of known inhibitors and substrates. Our study emphasizes the action of inhibitors at the Qi site on a highly unstructured portion of cytochrome b that could be related to the biological function of the electron transport chain complex. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic PLOS Neglected Tropical Diseases 17 1 e0010545 |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English |
topic |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Stefano Muscat Gianvito Grasso Leonardo Scapozza Andrea Danani In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi. |
topic_facet |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
description |
Chagas' disease is a neglected tropical disease caused by the kinetoplastid protozoan Trypanosoma cruzi. The only therapies are the nitroheterocyclic chemicals nifurtimox and benznidazole that cause various adverse effects. The need to create safe and effective medications to improve medical care remains critical. The lack of verified T. cruzi therapeutic targets hinders medication research for Chagas' disease. In this respect, cytochrome bc1 has been identified as a promising therapeutic target candidate for antibacterial medicines of medical and agricultural interest. Cytochrome bc1 belongs to the mitochondrial electron transport chain and transfers electrons from ubiquinol to cytochrome c1 by the action of two catalytic sites named Qi and Qo. The two binding sites are highly selective, and specific inhibitors exist for each site. Recent studies identified the Qi site of the cytochrome bc1 as a promising drug target against T. cruzi. However, a lack of knowledge of the drug mechanism of action unfortunately hinders the development of new therapies. In this context, knowing the cause of binding site selectivity and the mechanism of action of inhibitors and substrates is crucial for drug discovery and optimization processes. In this paper, we provide a detailed computational investigation of the Qi site of T. cruzi cytochrome b to shed light on the molecular mechanism of action of known inhibitors and substrates. Our study emphasizes the action of inhibitors at the Qi site on a highly unstructured portion of cytochrome b that could be related to the biological function of the electron transport chain complex. |
format |
Article in Journal/Newspaper |
author |
Stefano Muscat Gianvito Grasso Leonardo Scapozza Andrea Danani |
author_facet |
Stefano Muscat Gianvito Grasso Leonardo Scapozza Andrea Danani |
author_sort |
Stefano Muscat |
title |
In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi. |
title_short |
In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi. |
title_full |
In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi. |
title_fullStr |
In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi. |
title_full_unstemmed |
In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi. |
title_sort |
in silico investigation of cytochrome bc1 molecular inhibition mechanism against trypanosoma cruzi. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2023 |
url |
https://doi.org/10.1371/journal.pntd.0010545 https://doaj.org/article/0abe6a01cc204a61baced8f759d0fab2 |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
PLoS Neglected Tropical Diseases, Vol 17, Iss 1, p e0010545 (2023) |
op_relation |
https://doi.org/10.1371/journal.pntd.0010545 https://doaj.org/toc/1935-2727 https://doaj.org/toc/1935-2735 1935-2727 1935-2735 doi:10.1371/journal.pntd.0010545 https://doaj.org/article/0abe6a01cc204a61baced8f759d0fab2 |
op_doi |
https://doi.org/10.1371/journal.pntd.0010545 |
container_title |
PLOS Neglected Tropical Diseases |
container_volume |
17 |
container_issue |
1 |
container_start_page |
e0010545 |
_version_ |
1766341952501972992 |